CaDAnCe-101
BeOne Medicines
BeOne Medicines
Galapagos NV
Janssen Research & Development, LLC
National Institutes of Health Clinical Center (CC)
University of Chicago
Hoffmann-La Roche
University of California, San Diego
Genmab
Cho Pharma Inc.
Hoffmann-La Roche
Children's Oncology Group
Lyell Immunopharma, Inc.
AstraZeneca
Medical College of Wisconsin
Celgene
Essen Biotech
Vironexis Biotherapeutics Inc.
Werewolf Therapeutics, Inc.
University of Alberta
National Research Center for Hematology, Russia
Merck Sharp & Dohme LLC
Incyte Corporation
Eli Lilly and Company
University of Michigan Rogel Cancer Center
UNC Lineberger Comprehensive Cancer Center
Hoffmann-La Roche
Fred Hutchinson Cancer Center
CellCentric Ltd.
Incyte Corporation
M.D. Anderson Cancer Center
CRISPR Therapeutics
Ipsen
Washington University School of Medicine
CRISPR Therapeutics
Incyte Corporation
University of Texas Southwestern Medical Center
Acerta Pharma BV
Sichuan Baili Pharmaceutical Co., Ltd.
National Institutes of Health Clinical Center (CC)
Barbara Ann Karmanos Cancer Institute
Sichuan Baili Pharmaceutical Co., Ltd.
Sichuan Baili Pharmaceutical Co., Ltd.
Genmab
Genentech, Inc.
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
First Affiliated Hospital of Zhejiang University
Stanford University
Ottawa Hospital Research Institute
Juventas Cell Therapy Ltd.
Estrella Immunopharma, Inc.